Literature DB >> 11562294

Current aspects of pathophysiology and cell dysfunction after severe head injury.

J Sahuquillo1, M A Poca, S Amoros.   

Abstract

Traumatic brain injury is a major health problem in all developed countries. The main aim of this review is to provide a short update on the most recent advances in our knowledge of the brains response to mechanical injuries, focusing on metabolic, cellular, subcellular, and molecular events that take place in severe head injuries. Knowledge of these events is essential for a better understanding of new pharmacological avenues and non-pharmacological strategies, such as moderate hypothermia, which are being developed to improve the outcome of this silent epidemic. We will focus on several topics that we consider to be the most significant: diffuse axonal injury, ischemia and the cascades it generates, metabolic derangements, excitotoxicity, oxidative stress, and other phenomena that have been included in the term tertiary injuries. Recent evidence has clearly demonstrated that traumatic brain lesions are highly dynamic and that the different lesions observed after closed head injury are not single events but processes set in motion by the mechanical impact. These processes are not finished until an unpredictable time after injury. We will discuss recent evidence showing that in diffuse axonal injury, primary immediate damage can coexist with axons that, although initially intact, may be evolving towards secondary disconnection. The concept of ischemic penumbra and the more recent concept of traumatic penumbra are discussed, together with recent experimental and clinical data that shed light on the non-ischemic forms of brain hypoxia. The role of excitotoxicity in mechanically-induced cell death and the molecular events that excessive release of glutamate induce, including apoptosis and delayed inflammatory processes, are reviewed. Finally, new knowledge on how central nervous system cells regulate their volume, the new family of channel water molecules known as aquaporins and their possible role in the physiopathology of the swollen brain are discussed. Basic and clinical investigations are still needed to translate the huge amount of pathophysiological knowledge acquired in the last decade into effective treatments for these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11562294     DOI: 10.2174/1381612013397311

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  36 in total

Review 1.  A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.

Authors:  Kevin W McConeghy; Jimmi Hatton; Lindsey Hughes; Aaron M Cook
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

2.  Dynamics of cerebral edema and the apparent diffusion coefficient of water changes in patients with severe traumatic brain injury. A prospective MRI study.

Authors:  Anne Pasco; Aram Ter Minassian; Catherine Chapon; Laurent Lemaire; Florence Franconi; Dana Darabi; Christine Caron; Jean-Pierre Benoit; Jean-Jacques Le Jeune
Journal:  Eur Radiol       Date:  2006-02-17       Impact factor: 5.315

3.  Hypothermia decreases cerebrospinal fluid asymmetric dimethylarginine levels in children with traumatic brain injury.

Authors:  Bhavani P Thampatty; Megan M Klamerus; Patrick J Oberly; Kerri L Feldman; Michael J Bell; Elizabeth C Tyler-Kabara; P David Adelson; Robert S B Clark; Patrick M Kochanek; Samuel M Poloyac
Journal:  Pediatr Crit Care Med       Date:  2013-05       Impact factor: 3.624

4.  Vascular neural network phenotypic transformation after traumatic injury: potential role in long-term sequelae.

Authors:  J Badaut; G J Bix
Journal:  Transl Stroke Res       Date:  2013-11-29       Impact factor: 6.829

5.  Perfusional deficit and the dynamics of cerebral edemas in experimental traumatic brain injury using perfusion and diffusion-weighted magnetic resonance imaging.

Authors:  Anne Pasco; Laurent Lemaire; Florence Franconi; Yann Lefur; Fanny Noury; Jean-Paul Saint-André; Jean-Pierre Benoit; Patrick J Cozzone; Jean-Jacques Le Jeune
Journal:  J Neurotrauma       Date:  2007-08       Impact factor: 5.269

6.  Causal role of apoptosis-inducing factor for neuronal cell death following traumatic brain injury.

Authors:  Jennifer E Slemmer; Changlian Zhu; Stefan Landshamer; Raimund Trabold; Julia Grohm; Ardavan Ardeshiri; Ernst Wagner; Marva I Sweeney; Klas Blomgren; Carsten Culmsee; John T Weber; Nikolaus Plesnila
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

7.  Regional differences in cerebral edema after traumatic brain injury identified by impedance analysis.

Authors:  Matthew T Harting; Carter T Smith; Ravi S Radhakrishnan; Kevin R Aroom; Pramod K Dash; Brijesh Gill; Charles S Cox
Journal:  J Surg Res       Date:  2008-11-27       Impact factor: 2.192

8.  Dosing and safety of cyclosporine in patients with severe brain injury.

Authors:  Jimmi Hatton; Bonnie Rosbolt; Philip Empey; Richard Kryscio; Byron Young
Journal:  J Neurosurg       Date:  2008-10       Impact factor: 5.115

9.  Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases.

Authors:  Anna Vilalta; Juan Sahuquillo; Anna Rosell; Maria A Poca; Marilyn Riveiro; Joan Montaner
Journal:  Intensive Care Med       Date:  2008-03-19       Impact factor: 17.440

10.  Variation in chronic nicotinamide treatment after traumatic brain injury can alter components of functional recovery independent of histological damage.

Authors:  Michael R Hoane; Jeremy L Pierce; Nicholas A Kaufman; Jason E Beare
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.